Not Losing Weight? Why Increasing Your GLP-1 Dose Isn’t Always the Answer

One of the most common things we hear during a weight-loss journey is:

“I’m not losing anymore. Should I increase my dose?”

But there’s another question we need to ask first:

Are you actually hungry?

If your appetite is already significantly suppressed, automatically increasing medication may not address the reason your progress has slowed.

The goal isn’t to eat as little as possible.

GLP-1–based therapies can be incredibly effective tools for weight management, but medication is only one part of the equation.

As weight comes off, protecting lean muscle becomes increasingly important. If you’re eating very little, not prioritizing protein and not strength training, you may lose muscle along with fat.

And muscle matters.

It supports strength, function, body composition and daily energy expenditure. That’s why successful long-term weight management isn’t simply about making the number on the scale smaller.

Before assuming you need a higher dose, look at the basics.

Ask yourself:

• Am I getting enough protein?

• Am I drinking enough water?

• Am I strength training consistently?

• Am I walking and moving throughout the day?

• Am I sleeping enough?

• Am I tracking measurements and body composition—not just weight?

• Has my weight truly plateaued, or has the scale simply not moved for a week or two?

If you have virtually no appetite but aren’t exercising, the next step may be improving nutrition, movement and muscle preservation rather than simply trying to suppress your appetite even further.

And what about retatrutide?

Retatrutide is one of the most talked-about medications currently being researched for obesity.

Unlike medications that target GLP-1 alone, retatrutide is an investigational triple hormone receptor agonist that activates GIP, GLP-1 and glucagon receptors.

The research has been impressive. In the Phase 3 TRIUMPH-1 obesity trial, participants receiving the highest studied dose experienced an average weight reduction of 28.3% at 80 weeks. However, retatrutide remains investigational and is not currently FDA-approved or available for public use.

That distinction is important.

More medication—or a newer medication—isn’t automatically the solution to every plateau.

Medication is a tool. Your habits build the foundation.

The goal of a medically guided weight-loss program should never be to see how little you can eat.

It should be to help you:

✓ Lose excess body fat

✓ Preserve and build lean muscle

✓ Eat enough protein and nutrient-dense foods

✓ Become stronger and more active

✓ Improve your metabolic health

✓ Develop habits you can actually maintain

If your appetite is already extremely low, talk with your healthcare provider before making any medication changes. Your dose should be individualized based on your response, tolerance, health history and treatment goals.

Sometimes the answer isn’t “more.”

Sometimes it’s time to add the missing piece:

Protein. Movement. Strength. Consistency.

The scale is only one measurement of progress. Building a healthier, stronger body is the bigger goal.

Educational content only. GLP-1 and other prescription medication decisions should be made with a qualified healthcare provider. Retatrutide is investigational and has not been approved by the FDA.